Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM
Clinical trial NCT03927313 · COMPLETED
Trial details
- NCT number
- NCT03927313
- Sponsor
- University of Cape Town
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2021-03-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.